<SEC-DOCUMENT>0001628280-22-006255.txt : 20220315
<SEC-HEADER>0001628280-22-006255.hdr.sgml : 20220315
<ACCEPTANCE-DATETIME>20220315163110
ACCESSION NUMBER:		0001628280-22-006255
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220315
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220315
DATE AS OF CHANGE:		20220315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		22741560

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>csbr-20220315.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:20e339ca-2ac3-4e57-ae2b-b9857e0afd6a,g:ee33c00f-9506-41ec-ac6e-0d9747a555a0,d:cb56d16e2ec54adeab9638ebb719e09d--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>csbr-20220315</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF80L2ZyYWc6ODMxMDdhZThkYmU0NGUzMWIzZjAyNGZlMTY0YTRmNGEvdGFibGU6ZTkzODMyNzI5ZDI4NGI1Yjk2YjdmYTNlZTdiMjAyMDYvdGFibGVyYW5nZTplOTM4MzI3MjlkMjg0YjViOTZiN2ZhM2VlN2IyMDIwNl8wLTEtMS0xLTExODIw_b2441402-4c82-4805-bc58-e71ed975f7ac">0000771856</ix:nonNumeric><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF80L2ZyYWc6ODMxMDdhZThkYmU0NGUzMWIzZjAyNGZlMTY0YTRmNGEvdGFibGU6ZTkzODMyNzI5ZDI4NGI1Yjk2YjdmYTNlZTdiMjAyMDYvdGFibGVyYW5nZTplOTM4MzI3MjlkMjg0YjViOTZiN2ZhM2VlN2IyMDIwNl8xLTEtMS0xLTExODIw_0e68bc6e-60c3-4a43-ab30-ae25b3c8d2d1">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="csbr-20220315.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-15</xbrli:startDate><xbrli:endDate>2022-03-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icb56d16e2ec54adeab9638ebb719e09d_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUx_8ede74c5-24c6-48cd-9f39-3d97ac3f47dd">8-K</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8zODQ4MjkwNjk5NjIy_f0424bcf-d3b4-4e8c-b2c9-61f61028cc0e">March 15, 2022</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ2_3788ed89-c65d-4868-8d56-8b7cd8ccc49e">CHAMPIONS ONCOLOGY, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTAtMS0xLTExODIw_e27269dc-1864-468c-96b5-86ce77b00933">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTItMS0xLTExODIw_590fb0ef-d20a-4f03-94ab-9f5e5bce5e0e">001-11504</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTQtMS0xLTExODIw_a2b76a1a-0ea4-4658-8da2-5e0143bc71d0">52-1401755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU1_29eb2799-941d-42ae-abb6-c7f3f8794d57">1 University Plaza</ix:nonNumeric>, <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU2_0e9a4b53-a4ba-4196-9b3b-521efeca8da3">Suite 307</ix:nonNumeric>, <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ4_9e0a39f7-6780-48c3-b8ed-1aa0ef6a1c86">Hackensack</ix:nonNumeric>, <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ5_5bb85286-b3bb-437f-b76d-bb892efca23d">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUz_bea50686-a112-42bc-8bdd-45fc3f31eebe">07601</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl80ODM_9017b6a3-ac28-4903-ab3d-dc4a0dedb315">201</ix:nonNumeric>) <ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUw_aafe2903-cfa9-4198-8a4e-88bd305ea70f">808-8400</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address if Changed Since Last Report)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6NmVkZmI0MzJkNTAyNGE3MjkxZGFhZWU0YTAwMzVkMmIvdGFibGVyYW5nZTo2ZWRmYjQzMmQ1MDI0YTcyOTFkYWFlZTRhMDAzNWQyYl8wLTEtMS0xLTExODIw_892c2d42-a70f-4737-985a-2482fbc00fee">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6MGM1YzM0NzU0ZWIyNDEyOThkMTc4YmEwMDE0ZTYwZDQvdGFibGVyYW5nZTowYzVjMzQ3NTRlYjI0MTI5OGQxNzhiYTAwMTRlNjBkNF8wLTEtMS0xLTExODIw_28b00818-37f8-4890-ba4c-9d2b13253d4f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6ZWUxODEzYTA0MzI3NGU3NGE1ODVhM2I2ZWQ4MjhmMzMvdGFibGVyYW5nZTplZTE4MTNhMDQzMjc0ZTc0YTU4NWEzYjZlZDgyOGYzM18wLTEtMS0xLTExODIw_2946a3db-91b6-4652-91e1-cf2e85d72013">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6ZWZlYjQyNDFhMWQzNDNiYWIyN2VhOTAyNjQzN2QwODMvdGFibGVyYW5nZTplZmViNDI0MWExZDM0M2JhYjI3ZWE5MDI2NDM3ZDA4M18wLTEtMS0xLTExODIw_38e66d14-c235-4407-9286-d4f24177eadb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU0_57d09b75-d112-410d-858b-e3be3af08f71">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION TO BE INCLUDED IN THE REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:205.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On  March 15, 2022, Champions Oncology, Inc. (the &#8220;Company&#8221;) issued a press release regarding the Company&#8217;s unaudited financial results for its fiscal quarter ended January&#160;31, 2022. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained under Item 2.02 in this Current Report shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:213.75pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:153.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="padding-left:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibit is filed herewith:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit No.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:207.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:181.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k1312022ex991xq322.htm">Press Release Dated </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 15, 2022</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHAMPIONS ONCOLOGY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>csbr8-k1312022ex991xq322.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic9edc23c66754ace84bc4bfdc20cbc5d_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><img alt="logobranding_headerleftalia.jpg" src="logobranding_headerleftalia.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:666px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        NEWS</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One University Plaza, Suite 307 Hackensack, NJ 07601 Tel&#58; 551-206-8104</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Champions Oncology Reports Record Quarterly Revenue of $13.2 Million</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Reported Adjusted EBITDA of $1.5 million</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Hackensack, NJ &#8211; March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, 2022</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#8211; Champions Oncology, Inc. (Nasdaq&#58; CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its third quarter of fiscal 2022, ended January 31, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Quarter and Recent Highlights&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Record quarterly revenue of $13.2 million, an increase of 22% year over year</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Reported adjusted EBITDA of $1.5 million</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#00000a;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Gross margin for the nine months ended January 31, 2022 improved to 52%</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#00000a;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Signed co-development discovery partnerships with Fannin Innovation Studio and Gigamune</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Ronnie Morris, CEO of Champions, commented, &#8220;Our third quarter results represent an execution of our long term strategy to deliver strong growth in our core business while driving key strategic initiatives forward by investing in therapeutic  discovery. The co-development deals signed this quarter represent meaningful progress in our discovery efforts and provides external validation of our platform.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">David Miller, CFO of Champions, said, &#34;We achieved another quarterly revenue record reaching $13.2 million, which represents a year over year increase of 22% and positions the company to achieve the 15% - 20% revenue growth guidance for fiscal 2022.  Additionally, we exceeded 50% gross margin for the third sequential quarter demonstrating the leverage in our core business.&#8221; </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Fiscal Quarter Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For the third quarter of fiscal 2022, revenue increased 22% to $13.2 million compared to $10.8 million for the third quarter of fiscal 2021. The increase in revenue was due to continued demand and growth for our pharmacology studies, including in-vivo, ex-vivo and biomarker services. Total costs and operating expenses for the third quarter of fiscal 2022 were $12.4 million compared to $9.8 million for the third quarter of fiscal 2021, an increase of $2.5 million or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">25.8%</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the third quarter of fiscal 2022, Champions reported net income from operations of $830,000, including $310,000 in stock-based compensation and $396,000 in depreciation and amortization expenses, compared to net income from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">operations of $982,000, inclusive of $232,000 in stock-based compensation and $297,000 in depreciation and amortization expenses, in the third quarter of fiscal 2021. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported adjusted EBITDA of $1.5 million for both the third quarter of fiscal 2022 and the third quarter of fiscal 2021.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology solutions was $6.4 million for the three-months ended January&#160;31, 2022, an increase of $1.8 million, or 38.6% compared to $4.6 million for the three-months ended January&#160;31, 2021. For the three-months ended January&#160;31, 2022, gross margin was 51.4% compared to 57.2% for the three-months ended January&#160;31, 2021. The increase in cost of sales was primarily related to compensation and lab supply expenses resulting from the increase in study volume. Cost of sales for the third quarter of fiscal year 2021 was atypically low resulting in a temporary, inflated gross margin. The decrease in gross margin from the third quarter of fiscal year 2021 does not represent a systemic decline.   </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Research and development expense for the three-months ended January&#160;31, 2022 was $2.2 million, an increase of $302,000 or 16.1%, compared to $1.9 million for the three-months ended January&#160;31, 2021. The increase was primarily the result of increased investment in our therapeutic target discovery platform. Sales and marketing expense for the three-months ended January&#160;31, 2022 was $1.5 million, an increase of $57,000, or 3.8%, compared to $1.5 million for the three-months ended January&#160;31, 2021. General and administrative expense for the three-months ended January&#160;31, 2022 was $2.2 million, an increase of  $391,000, or 21.3%, compared to $1.8 million for the three-months ended January&#160;31, 2021. The increase was primarily due to an increase in compensation and IT related expenses for infrastructure investment to support business growth.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Net cash generated from operating activities for the quarter was $4.3 million resulting from increased operating income excluding stock-based compensation and other non-cash related expenses and an increase in deferred revenue stemming from our bookings growth. Net cash used in investing activities was $404,000 primarily from investment in additional lab equipment and software development. The Company ended the quarter with a strong cash position of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$8.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> and no debt.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Year-to-Date Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first nine months of fiscal 2022, revenue increased 19% to $36.2 million compared to $30.5 million for the first nine months of fiscal 2021. The increase in revenue was due to the expansion of our platforms, business lines, and demand for our services. Total costs and operating expenses for the first nine months of fiscal 2022 were $35.3 million compared to $29.5 million for the first nine months of fiscal 2021, an increase of $5.9 million or 20%. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first nine months of fiscal 2022, Champions reported net income from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$918,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, including $724,000 in stock-based compensation and $1.1 million in depreciation and amortization expenses, compared to income from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">operations of </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.0 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, inclusive of $437,000 in stock-based compensation and $881,000 in depreciation and amortization expenses, in the first nine months of fiscal 2021. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported adjusted EBITDA of </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.7 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first nine months of fiscal 2022 compared to non-GAAP income from operations of </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.3 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the first nine months of fiscal 2021.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology solutions was </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$17.4 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the nine-months ended January&#160;31, 2022, an increase of </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$1.8 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, or </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.6%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> compared to </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$15.6 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the nine-months ended January&#160;31, 2021.  The increase was attributable to an increase in compensation and lab supply expenses due to our increase in study volume. For the nine-months ended January&#160;31, 2022, gross margin was </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">51.9%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> compared to </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">48.8%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the nine-months ended January&#160;31, 2021.  The improvement in gross margin was the direct result of decreasing the Company&#8217;s reliance on outsourcing and leveraging revenue growth over the fixed cost component of cost of sales. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Research and development expense for the nine-months ended January&#160;31, 2022 was </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.8 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, an increase of </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$1.7 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> or </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">32.4%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, compared to </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.1 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> for the nine-months ended January&#160;31, 2021. The increase was primarily from increased investment in our therapeutic target discovery platform. Sales and marketing expense for the nine-months ended January&#160;31, 2022 was </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$4.8 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, an increase of $716,000, or </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">17.7%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, compared to </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$4.0 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> for the nine-months ended January&#160;31, 2021. The increase was primarily due to compensation expense driven by the continued investment in expanding our business development teams. General and administrative expense for the nine-months ended January&#160;31, 2022 was </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.4 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, an increase of  </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$1.7 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, or </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">35.6%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, compared to </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$4.7 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> for the nine-months ended January&#160;31, 2021. The increase was primarily due to an increase in compensation as well as an increase in IT related expenses to support the overall infrastructure growth of the organization.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Net cash provided by operating activities was $5.7 million for the nine-months ended January&#160;31, 2022. The cash generated from operating activities was primarily due to increased operating income excluding stock-based compensation, depreciation and amortization expenses. Net cash used in investing activities was $1.9 million and was primarily from investment in additional lab equipment and software development. Net cash provided by financing activities was approximately $191,000 generated from option exercise activity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conference Call Information&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company will host a conference call today at 4&#58;30 p.m. EDT (1&#58;30 p.m. PDT) to discuss its third quarter financial results. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To participate in the call, please call </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 692343</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> ten minutes ahead of the call.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Full details of the Company&#8217;s financial results will be available by Wednesday, March 16, 2022 in the Company&#8217;s Form 10-Q at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#333366;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">www.championsoncology.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">* Non-GAAP Financial Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">See the attached Reconciliation of GAAP net income to Non-GAAP net income for an explanation of the amounts excluded to arrive at Non-GAAP net income and related Non-GAAP earnings per share amounts for the three and nine months ended January&#160;31, 2022 and 2021. Non-GAAP financial measures provide investors and management with supplemental measures of operating performance and </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">trends that facilitate comparisons between periods before and after certain items that would not otherwise be apparent on a GAAP basis. Certain unusual or non-recurring items that management does not believe affect the Company&#8217;s basic operations do not meet the GAAP definition of unusual or non-recurring items. Non-GAAP net income and Non-GAAP earnings per share are not, and should not, be viewed as a substitute for similar GAAP items. Champions defines Non-GAAP dilutive earnings per share amounts as Non-GAAP net earnings divided by the weighted average number of diluted shares outstanding. Champions&#8217; definition of Non-GAAP net earnings and Non-GAAP diluted earnings per share may differ from similarly named measures used by other companies.  </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization, and stock-based compensation expenses. Adjusted EBITDA represents a measure that Champions believes is customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. The Company's management also believes that adjusted EBITDA is useful in evaluating our core operating results. However, adjusted EBITDA is considered to be Non-GAAP in nature and should not be considered an alternative to net income or operating income as an indicator of Company operating performance or to net cash provided by operating activities as a measure of its liquidity. The company&#8217;s adjusted EBITDA measure may not provide information that is directly comparable to that provided by other companies in the Company's industry, as other companies in its industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Champions Oncology, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Champions Oncology is a data-driven research organization, with headquarters in the United States, that develops innovative therapeutics against cancer targets, offers ground breaking research software as a service, and provides end-to-end R&#38;D services to biopharma organizations.  Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain &#34;forward-looking statements&#34; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as &#34;believe,&#34; &#34;may,&#34; &#34;could,&#34; &#34;will,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;anticipate,&#34; &#34;plan,&#34; and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2021 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ic9edc23c66754ace84bc4bfdc20cbc5d_4"></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Champions Oncology, Inc.</font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in thousands)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Net Income (unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - Non-GAAP</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP EPS to Non-GAAP EPS (unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; GAAP, basic</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Non-GAAP, basic</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; GAAP, diluted</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Non-GAAP, diluted</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology services revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,812&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,232&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,476&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,623&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,411&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,603&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,181&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,879&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,783&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,048&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,836&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,356&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,686&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">830</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">982</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,014</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">787</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">959</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">892</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,035</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,500,444&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,371,613&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,170,880&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974,470&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,387,009&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,507,155&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178,082&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,510,280&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.807%"><tr><td style="width:1.0%"></td><td style="width:65.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 31, 2022</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,687&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,563&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,986&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,825</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,630</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,521&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,991&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,090&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,584</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,591</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,769&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,125&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,499</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,199</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,618&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,783&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non-current Liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,348&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,163&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,236&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,428&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,584</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,591</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Cash Flows (unaudited)</font></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.674%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operations&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on termination of operating lease</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on disposal of equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,254)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,701</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">299</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,878)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,427)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refund of security deposit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities&#58;</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,878)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,335)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease payments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by  financing activities&#58;</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,014&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(913)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at beginning of period</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,687&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,342&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at the end of period</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,701</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,429</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,872&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment acquired in accounts payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>csbr-20220315.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:20e339ca-2ac3-4e57-ae2b-b9857e0afd6a,g:ee33c00f-9506-41ec-ac6e-0d9747a555a0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:csbr="http://championsoncology.com/20220315" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://championsoncology.com/20220315">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220315_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20220315_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://championsoncology.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>csbr-20220315_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:20e339ca-2ac3-4e57-ae2b-b9857e0afd6a,g:ee33c00f-9506-41ec-ac6e-0d9747a555a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_5ab62c42-6b59-4dec-93a3-d7cbecca37b8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_24c06911-cc17-4df6-9118-3f53a3f23fd3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9e7e8b48-1dde-493a-8bb8-2f04eadb7b1a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5b341579-da3a-4912-8f74-ddb8e681967a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7cc00ae8-986f-4a27-9dfb-a362b85cac5b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f6076312-c61e-4248-b647-cd8d99552849_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_48ca25ab-f0b7-4c06-a003-f98e859466a4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a1ef12f9-1a4f-4a16-8da0-a8818a68bea0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c6590235-a445-4a02-b894-79d86bdf5814_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_74c2d6f1-3028-4471-9d22-af7d0b411ba0_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d5ad7e58-7b0e-46a2-9c39-9ec48fd84df3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_306a1a63-ed3d-4468-b0ea-a9f46177de07_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e0f7df23-b3a5-478d-9f97-b62c9b691f83_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dcf1d4f1-07b7-49f3-9b49-ca594841b48b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_18282790-9286-4070-b007-de49011986b5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_8d626f02-54da-4c9a-a1ef-2b08acff1320_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2dfce78a-88b7-445d-8d44-9c9eae0a01af_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3bf51bf2-60e1-4a0f-b7fe-93cff0ad42c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_30652338-6d4c-4351-8416-d7796168157e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9c64d9ac-2219-4d1d-a852-49e47937162b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>csbr-20220315_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:20e339ca-2ac3-4e57-ae2b-b9857e0afd6a,g:ee33c00f-9506-41ec-ac6e-0d9747a555a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20220315.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2467c535-eddd-4dba-8e6a-bbe086ddd373" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_DocumentType_2467c535-eddd-4dba-8e6a-bbe086ddd373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_385262ea-3bad-4ba5-81d6-8b0f100b59b1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_DocumentPeriodEndDate_385262ea-3bad-4ba5-81d6-8b0f100b59b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9541f859-57d1-46b3-93b0-6db178c9d257" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityRegistrantName_9541f859-57d1-46b3-93b0-6db178c9d257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13861df9-098d-4626-8fd9-c19fd1578de6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13861df9-098d-4626-8fd9-c19fd1578de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_aeca1bdb-a551-48e5-b000-90751c66d6c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityFileNumber_aeca1bdb-a551-48e5-b000-90751c66d6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_43c20f61-705b-4cd8-a116-5faf817e858e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityTaxIdentificationNumber_43c20f61-705b-4cd8-a116-5faf817e858e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3ddc5931-0463-4585-9f6d-4d70b57c9943" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityAddressAddressLine1_3ddc5931-0463-4585-9f6d-4d70b57c9943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_9bb0cff2-47a7-48c4-af8e-253257aed6dd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityAddressAddressLine2_9bb0cff2-47a7-48c4-af8e-253257aed6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_095339c0-02e9-4ed0-8ce8-0afe04677d14" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityAddressCityOrTown_095339c0-02e9-4ed0-8ce8-0afe04677d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6ff2c150-0c52-4389-b6b0-46f42cdfd0a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityAddressStateOrProvince_6ff2c150-0c52-4389-b6b0-46f42cdfd0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d10025e0-2036-41ab-9515-0f881da90d53" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityAddressPostalZipCode_d10025e0-2036-41ab-9515-0f881da90d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8f8f0da1-bf61-4072-bf6f-4d4dea6c5325" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_CityAreaCode_8f8f0da1-bf61-4072-bf6f-4d4dea6c5325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_813dd65f-0dfc-4c24-9c29-2e5bff3f2cc9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_LocalPhoneNumber_813dd65f-0dfc-4c24-9c29-2e5bff3f2cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c3ee2f3f-6e98-458f-9e68-6a03ad7c0f38" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_WrittenCommunications_c3ee2f3f-6e98-458f-9e68-6a03ad7c0f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7088c28a-8416-4794-921b-0e46ad3ce061" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_SolicitingMaterial_7088c28a-8416-4794-921b-0e46ad3ce061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f6832ab4-6f65-4517-a6c8-7929a6e9ab1e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_PreCommencementTenderOffer_f6832ab4-6f65-4517-a6c8-7929a6e9ab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_101e0514-b514-41b9-9cb4-98c2eba9079c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_101e0514-b514-41b9-9cb4-98c2eba9079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1df4d56d-34c5-4759-b40d-1870a713e33e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityEmergingGrowthCompany_1df4d56d-34c5-4759-b40d-1870a713e33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_86b6ba35-ea88-4b4b-8887-8724c2bfde24" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_EntityCentralIndexKey_86b6ba35-ea88-4b4b-8887-8724c2bfde24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c02621c6-7def-4132-b17c-724d5d0f73b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bbcbec61-04fe-45bc-a782-6dccade1180a" xlink:to="loc_dei_AmendmentFlag_c02621c6-7def-4132-b17c-724d5d0f73b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logobranding_headerleftalia.jpg
<TEXT>
begin 644 logobranding_headerleftalia.jpg
M_]C_X0E@17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"D ,C R,#HP-3HQ-" Q,#HU-SHT,P
M  .@ 0 #     ?__  "@ @ $     0   S2@ P $     0   5X
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   ()@        !(     0   $@
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MJ22GZJ27RJDDI^JDE\JI)*?_V?_M$>Q0:&]T;W-H;W @,RXP #A"24T$)0
M    $                      X0DE-!#H      0L    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585    !0 0P!A &X ;P!N "  5 !2 #@ -0 P #  ( !S &4
M<@!I &4 <P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 2P    !  $!+     $  3A"
M24T$)@      #@             _@   .$))300-       $    6CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-!
M      ( "SA"24T$ @      &                                #A"
M24T$,       # $! 0$! 0$! 0$! 3A"24T$+0      !@ !    ##A"24T$
M"       $     $   )    "0      X0DE-!!X       0     .$))300:
M      .+    !@             !7@   S0    K $P ;P!G &\ ( !" '(
M80!N &0 :0!N &< 7P!( &4 80!D &4 <@ @ $P 90!F '0 ( !! &P :0!G
M &X 90!D "  =P!I '0 :  @ $< <@!I &0    !
M      $              S0   %>                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     PX0DE-! P     "$(    !    GP
M $0   '@  !_@   ""8 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $0 GP,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MI>3JS^3_ )Z;PR[+N(=V\DL\=:Q-99<($NBI[@/:VR/4J;94_P!KO\&]^_\
MP:MX][<BH6L:YK73 >TL=II]!\/2((W"@0=BE22202I))))3_]+U5))))2DD
MDDE*3$ B#J"G224I))))2DT"9[ITDE*30)GNG224M ^Y.DDDI22222E))))*
M4DDDDI__T_54E\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V3A"24T$(0
M5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #  ,@ P     0 X
M0DE-! 8       < ! $!  $! /_A$BQH='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#8N,"UC,# R(#<Y+C$V
M-#,U,BP@,C R,"\P,2\S,"TQ-3HU,#HS." @(" @(" @(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL;G,Z<&AO=&]S:&]P/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(B!X;7 Z0W)E871O
M<E1O;VP](D%D;V)E(%!H;W1O<VAO<" R,2XQ("A-86-I;G1O<V@I(B!X;7 Z
M0W)E871E1&%T93TB,C R,"TP-2TQ-%0Q,#HU-SHP,RTP-SHP,"(@>&UP.DUE
M=&%D871A1&%T93TB,C R,"TP-2TQ-%0Q,#HU-SHT,RTP-SHP,"(@>&UP.DUO
M9&EF>41A=&4](C(P,C M,#4M,314,3 Z-3<Z-#,M,#<Z,# B(&1C.F9O<FUA
M=#TB:6UA9V4O:G!E9R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#IE.65A
M9C0R-"UC,F,U+30U-#4M.#1B,2TW931F9C$T,&(R,#@B('AM<$U-.D1O8W5M
M96YT240](F%D;V)E.F1O8VED.G!H;W1O<VAO<#IE9#5A-SAF."TR93=A+60P
M-#@M8C$Q."UC-3AD,F$U9&1D,V$B('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#TB>&UP+F1I9#HR-SDT8C1D,BUC.34T+30T-S8M83$X.2TS-#4R-CDP.#(Y
M-V,B('!H;W1O<VAO<#I#;VQO<DUO9&4](C,B/B \>&UP34TZ2&ES=&]R>3X@
M/')D9CI397$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C<F5A=&5D(B!S=$5V
M=#II;G-T86YC94E$/2)X;7 N:6ED.C(W.31B-&0R+6,Y-30M-#0W-BUA,3@Y
M+3,T-3(V.3 X,CDW8R(@<W1%=G0Z=VAE;CTB,C R,"TP-2TQ-%0Q,#HU-SHP
M,RTP-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@4&AO=&]S:&]P
M(#(Q+C$@*$UA8VEN=&]S:"DB+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](G-A
M=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED.C%E-30Y-S0V+3(S-&,M
M-&%B8BTY-SDT+68R-34Y-V(Q-S@S9B(@<W1%=G0Z=VAE;CTB,C R,"TP-2TQ
M-%0Q,#HU-SHT,RTP-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@
M4&AO=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"DB('-T179T.F-H86YG960](B\B
M+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](F-O;G9E<G1E9"(@<W1%=G0Z<&%R
M86UE=&5R<STB9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P
M('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](F1E<FEV
M960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T
M:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O:G!E9R(O/B \<F1F
M.FQI('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM
M<"YI:60Z93EE868T,C0M8S)C-2TT-30U+3@T8C$M-V4T9F8Q-#!B,C X(B!S
M=$5V=#IW:&5N/2(R,#(P+3 U+3$T5#$P.C4W.C0S+3 W.C P(B!S=$5V=#IS
M;V9T=V%R94%G96YT/2)!9&]B92!0:&]T;W-H;W @,C$N,2 H36%C:6YT;W-H
M*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B \+W)D9CI397$^(#PO>&UP34TZ2&ES
M=&]R>3X@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM
M<"YI:60Z,64U-#DW-#8M,C,T8RTT86)B+3DW.30M9C(U-3DW8C$W.#-F(B!S
M=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.C(W.31B-&0R+6,Y-30M-#0W-BUA
M,3@Y+3,T-3(V.3 X,CDW8R(@<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)X
M;7 N9&ED.C(W.31B-&0R+6,Y-30M-#0W-BUA,3@Y+3,T-3(V.3 X,CDW8R(O
M/B \<&AO=&]S:&]P.E1E>'1,87EE<G,^(#QR9&8Z0F%G/B \<F1F.FQI('!H
M;W1O<VAO<#I,87EE<DYA;64](D-R96%T:6YG($=R96%T97(@0V5R=&%I;G1Y
M($EN('1H92!&:6=H="!!9V%I;G-T($-A;F-E<B(@<&AO=&]S:&]P.DQA>65R
M5&5X=#TB0W)E871I;F<@1W)E871E<B!#97)T86EN='D@26X@=&AE($9I9VAT
M($%G86EN<W0@0V%N8V5R(B\^(#QR9&8Z;&D@<&AO=&]S:&]P.DQA>65R3F%M
M93TB0W)E871I;F<@1W)E871E<B!#97)T86EN='D@26X@=&AE($9I9VAT($%G
M86EN<W0@0V%N8V5R(&-O<'DB('!H;W1O<VAO<#I,87EE<E1E>'0](D-R96%T
M:6YG($=R96%T97(@0V5R=&%I;G1Y($EN('1H92!&:6=H="!!9V%I;G-T($-A
M;F-E<B(O/B \+W)D9CI"86<^(#PO<&AO=&]S:&]P.E1E>'1,87EE<G,^(#PO
M<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0](G<B/S[_[@ A061O
M8F4 9      ! P 0 P(#!@               /_; (0 !@0$! 4$!@4%!@D&
M!08)"P@&!@@+# H*"PH*#! ,# P,# P0# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# $'!P<-# T8$! 8% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,_\( $0@!7@,T P$1  (1 0,1
M ?_$ 0$  0 " P$! 0             %!P0&" ," 0$!  (# 0
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M$0   .J0
M
M
M
M
M
M
M
M    "/WTU&Q6C=],_3?;J]B3TD
M             &EV:O/G7X]<7*7QG 'UA8E.[T#R>QO56V
M                               !1O4Y7.G8XOGG   'UA?G*Z_0?([(
M                                            %)=/E<U]KB #TQF3
MTWCM]/'. )Z&;L[SGII6.0
M     #59Z_%WI?,>.<"1TWZ*X_:MSG]'*UV\,XJR_P _G'L<7UQGL'SWI-BA
MF                                            '+/=X%2=#G#.TW[
M'\[Z7;*]@ " EA^,MBAF
M    'EG'!WJO)8FVHZ.XW:O/E]8:39JT[T>9LL,]W\SJ^F,@1N^DCIN/C./3
M&?+./7&1B;:Y>NP\<X]L9^,X \F/?&WZ>.<>V,B/WTS==OO&?/./O&1\9QZ8
MSC;:^N,^F,@                           :Q/!Q+Z;RP'<WE_5S<4L/)
M%Q#Z?RV)MJ+^Y/7Z#Y'9^,XY.[WGO3&9/3>[>9U:7Z?+Z(X_:Y6[OG^N?/\
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M_5+%?ZPJ^]0W6M:R]=K6H=#FCM<.SJ5[H#D]C[QD
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M_:J]BQJ=W2[-67CD^F8"6':H+%47^?*1[VG1Z
M      YG[7#I;I\L>^N>N?/^CL&I<  TZS6^&-TK6@  /+.*:Z7,VVO8CM])
M'3?8X9ZEO\ZT:-^L;U&QJ5V/WTWNK;IOH\R<CEEHY-%M5=QK6?S+9X)Y6.0
M                              ""EAXI]+YC!WT'MC-Y\OK6[S^C/0RP
MTL=3W^=0_5Y/MC/7/G_1[O5M  #2[-6#EBTVS5QLXKZW3MWG]&T:-^O;E/<:
MUFK[U#,UVM>AT:QNT(:6+ZQF;CEL&G<H7K<CI_A]X
M             "KKU#E/O>?\\X    S]-^W/,^IEHY  !5-_G[C7L^3&-MKL
MT$]67Z%ETKU;7*-C4[VC6JD]%+#21SD4LAKOH=JI:]#H:U-!M4%@
M                         5A>H<N=S@X&^@  &7KMTOQ>Y;_.Z0
M                                       $-)%1'5Y-37^=#RQ@2D<E
MK4.A?'*ZT_%,                                               !
M"RQ8.VF9KO-Q2_H
M
M                                              ,?.,C&0
M,?.,C&0  //./P]<9 Q\X]\9\,ZY&-@ ,?.,C&0
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MBEV:&8
M
M
M
M
M
M
M
M
M
M
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M%F*WH#0D\9$@I*G*?EYIX@5K)"N@> O ;HCIW)"FG7S<7S"+QIK[ES1/FO\
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M.,BHW\85-.!TEPQC_%QH30L6VNF83;:\7XP.Z_*ATQ#!O3K:&,>&+2DG-&(
MME(CHZD>.+2:>QX.%T?A8@"V6I$='4CQT:&3%1W3#*-CP7'BIZ>8%Q%Q0Z9@
M-@NI,47=,,HV+S(N#&ABTKC8FAXL%TUCFP7XUDV>1<!)46)+1U/#)E"TD64+
MJ>-51$7($2QI@NZ>G(VY+E>DCSPMC^8GI'Q]/\Q-=1Y(NHS)ZW-'D%4HTU'%
MDRA:1)YHLJ032/3!!MHB(?(+[*. 8**\$)45C)JF@EM%KK'1RFQT_D]$:DK;
MB@L64+J>*:BJUCS'T@5"E26D<D/&:#E47I%T.C(KU,QG ].!_-Z*O*0]_,,6
M8]#ZH4F4J#(F.NAH4]1J+'YN^0YL3U$5.7\(#459(B'Q.8ULE8C TBQA5R1$
M!W1@A)^5M\Q:%!+&-JK3(MHYCFR*/$%K3N/;-6(@-:>8%Q!QC:*B(B-QA _(
MDN$CFC;(%\8@I+$@('EYUD7$>QA)HV3#P T1:9QA+IE@&T\PDP"Z^U:T+#:?
MY,B)$3_ D2(GC541$5%3BA(O 20D\*DB?&G3Z1:C"X*OFKCLY45QX^HI)DR9
M&B.23ZCE*@1'3<1U>MQEQL&UDD(,RE4ONG-=;A/.SE17'SZS-1!J,+@NS513
MD%U.&\KCD@^I7B(7))HKSQD/KD)QS(A;+Z@27%T^:@!DX,=ETA(9Q$3Y](0V
M@30R5%I))J$<S!6#<-R2]Z80N0D$QPR.4>E<52.6?)^00E)<<YHJH++"/";Q
M(7W1]#<DN;3KBHW-(B1\R/X<8H2-,$"M,]"A#Z3<C*I'%Y@K',_MEZ9*IU1E
M)0=CJI+#^F^PC@MQ^0-Q%10847 A])@SR,Q0D:8(%^SY&C/U%87U'(BDOVZ=
M2Q5Z'8ZDKJ(\YI(O)O[=.I]KU *.I#Z'XH\56UD,^H#@=0R>0HVV3K7H_498
M4%<80S<;1K4->1%!YZ]'ZGVGTWHQ.*XPI$J::C$"N1%4OMTYI&_D#"H,>*K:
ML,]"?[5/_]H " $!  $% /\ 6[RUBP&'";OOM9$+_L=MGJ'OWM9*+#VBN9H?
M,%^W9J=,;M^_U\SY////N\6G7&G*COS?J^=!WCJ-Q\O;P;]#C3???D/>-MPV
MSVCW_<1P20D\M;^;N'B6O Q'D2'!IUN(9,.7%<XTNEYNWYNJ5YJNU[RSN;=V
M:;4I<N3,E<,!7LS8,I1>VZO8YK&XG%8N/J; @SF+MVZ5+,MVJHYZK96ETO-V
M_-T6BX2FX3RUW'VX\K<^&#PF2SF6VXVZQ%)PGANE)P=OPU%HN$IN$\M2I+,6
M+E\E(RF5X=LM*;CXOAN'NU6*2$WNEMYOU+N>QTN5%E1I<?B[9JVT^!@8&8 +
M4J,\JJB(W,B.GHB04C9?$RG=*J(@38;AZ=D,,Z:>9>%V0PSK\QQ^@,#'2S8:
M'PEV' 0WF7F7VM.R([.@<!P#<!L&I,9Y=2LIC(AQY,>2U\9W/F%#V[XT?$AB
M*=JXV-FMU?*Y2?ELEP[9+O)61IYYIAG<K=NR7;,1NW#<IZ!LWB=U</?-W_VS
M[6O[OL/Z!V]?NGK?BW_\=H5.L4FLV>)+CS(EA_0,?D)F.GT"\X^V5+=_<!RY
MVOM=_L#NL_3ZEL[=+5AR/</:ZQ4ZR,66L9'][M;R;U9C)Y;#]O.Y&4@MR=Q=
MK;#M[=H-RK'=?K8/=-*_D=[?VL[5_P!?WNO$^HTRE[5W7<)G$;;[PU6W,BX+
M7QC>@72VOXL$T3.M_P!EYS:OCV]LON;J:WCEO1=L>V;&0I=]URUN_P#MG2[U
MGZ=/E=PVX\J+V]?NGK?RTN63<#>6D8#&4;MPM_YO3;#^@;=U(+;9&,Y:JLSE
M:!)Q.W7:[_8'=9^G[.[Q4NJTO>?<B#>,[M+@IF"VZR/[W6Z9(@U38G%PLCN=
MKN3Q4&5M[VIRW^KNOU-V\FIMUCMU/SW9WM7_ %_>2AR[G3\9GMR-N)]/[GGR
MDQY#,ACXQN/ *?0>.W&:#-436:Q$/,8B[TK,5#/:1.>NWG;697\=JS8)C/5Z
MOYBP[9WR-W%[9.P*QW'Q,Q=MW_VS[7V&7K=8,? 3 ]O7[I[@6EJK5"E;>VB^
M2_\ K/N-K:C/RZ/N;8?T#MZ_=.^[*8JUW'NA;;:IG:[_ &!W6?I^TVR%4N%/
MJ6Q] K4O61_>Z5&9E1<OC+%MG?L)W'[=S8&\V\0W5>WZC2ZU4^Z_6PL2-,VB
MW:VVDTFP]J_Z_NUN:Q1<)@^X?;O-8W=:?0YUIVTAS(>W_P 8=;;=;LF'=PM@
MX=LMZ;;+A8:S@;% F]L%%>?J.R=!K$KC=MM:E<FC[5<,K]&VAIM.<L^ C6'
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MHDB7:2VLD+A=Q7\:SG=KIF;ETBR;;SY=G=V:;<H]]HD"WURO[;.0*U@=H,A
MRF%H,_$7?$;++A[-B:8L&[YC%0LOBJCM_9Z](795(]K8I8AN#*H,]=PL[LY-
MGY =N8XV ]I7UJ]EVSD9&?:H>.W-W!   (VU+D>BKMTPN?O=2:MM5R.V^4RV
M&';V.]9J'M+)J64W!IY6^LV+!KE:SN)]AAF:[6<W>=L$I*+?Z)09]3F9W;Z)
MG[=;:XU11V>D%'MF0V+D28Z4?E?1V:_]!NNVF:M4BR[<R\CGGV&I#%:VQL%;
MD9_:"9D,P.V; Y.-M;&+'X&@9>/@J!M5)J.0HE+&JP_]JG__V@ ( 0("!C\
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M3@N/8.;E3'+XN+SQ*QAE87X%I9814GD>,5A/WK,5;(_?_DR86_X)A;[!@F/
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M-RAM/*Z[9(GT]A_%P+,MNQ!8V@M2:O(TH.G=N4-%_P!9PF*EQKU\-=9*^/F
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MTET]B9*=')YMEFL;)9^R6KI++$7C ;Y3M&]U^)*NY=JINW?.9KDM>K5C-?\
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M9:%J[&K2K8Z.)'5U)CBKC9O/,W;FW>7CIRWD>I9LG6Z:YJT:+5HX8Q&\>R(
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M2,F8,B'("_D[AK^*R-Y<Q[.;\,MX/B;Y/)Y>)ZMCJ:2#IJRT;RX84Z\C*T8
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EBUFL,H/>[<9&)K?SUG)WYLA8L<OE>*;3PA=\G8NWVO\ W53_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140675531212472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 15,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHAMPIONS ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1401755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 University Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>csbr-20220315_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="csbr-20220315.xsd" xlink:type="simple"/>
    <context id="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2022-03-15</startDate>
            <endDate>2022-03-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF80L2ZyYWc6ODMxMDdhZThkYmU0NGUzMWIzZjAyNGZlMTY0YTRmNGEvdGFibGU6ZTkzODMyNzI5ZDI4NGI1Yjk2YjdmYTNlZTdiMjAyMDYvdGFibGVyYW5nZTplOTM4MzI3MjlkMjg0YjViOTZiN2ZhM2VlN2IyMDIwNl8wLTEtMS0xLTExODIw_b2441402-4c82-4805-bc58-e71ed975f7ac">0000771856</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF80L2ZyYWc6ODMxMDdhZThkYmU0NGUzMWIzZjAyNGZlMTY0YTRmNGEvdGFibGU6ZTkzODMyNzI5ZDI4NGI1Yjk2YjdmYTNlZTdiMjAyMDYvdGFibGVyYW5nZTplOTM4MzI3MjlkMjg0YjViOTZiN2ZhM2VlN2IyMDIwNl8xLTEtMS0xLTExODIw_0e68bc6e-60c3-4a43-ab30-ae25b3c8d2d1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUx_8ede74c5-24c6-48cd-9f39-3d97ac3f47dd">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8zODQ4MjkwNjk5NjIy_f0424bcf-d3b4-4e8c-b2c9-61f61028cc0e">2022-03-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ2_3788ed89-c65d-4868-8d56-8b7cd8ccc49e">CHAMPIONS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTAtMS0xLTExODIw_e27269dc-1864-468c-96b5-86ce77b00933">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTItMS0xLTExODIw_590fb0ef-d20a-4f03-94ab-9f5e5bce5e0e">001-11504</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6YTM2MzAwMjEyZDIxNGU5Nzg2OTI2MTdhNmUxZGI3ZDQvdGFibGVyYW5nZTphMzYzMDAyMTJkMjE0ZTk3ODY5MjYxN2E2ZTFkYjdkNF8wLTQtMS0xLTExODIw_a2b76a1a-0ea4-4658-8da2-5e0143bc71d0">52-1401755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU1_29eb2799-941d-42ae-abb6-c7f3f8794d57">1 University Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU2_0e9a4b53-a4ba-4196-9b3b-521efeca8da3">Suite 307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ4_9e0a39f7-6780-48c3-b8ed-1aa0ef6a1c86">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjQ5_5bb85286-b3bb-437f-b76d-bb892efca23d">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUz_bea50686-a112-42bc-8bdd-45fc3f31eebe">07601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl80ODM_9017b6a3-ac28-4903-ab3d-dc4a0dedb315">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjUw_aafe2903-cfa9-4198-8a4e-88bd305ea70f">808-8400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6NmVkZmI0MzJkNTAyNGE3MjkxZGFhZWU0YTAwMzVkMmIvdGFibGVyYW5nZTo2ZWRmYjQzMmQ1MDI0YTcyOTFkYWFlZTRhMDAzNWQyYl8wLTEtMS0xLTExODIw_892c2d42-a70f-4737-985a-2482fbc00fee">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6MGM1YzM0NzU0ZWIyNDEyOThkMTc4YmEwMDE0ZTYwZDQvdGFibGVyYW5nZTowYzVjMzQ3NTRlYjI0MTI5OGQxNzhiYTAwMTRlNjBkNF8wLTEtMS0xLTExODIw_28b00818-37f8-4890-ba4c-9d2b13253d4f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6ZWUxODEzYTA0MzI3NGU3NGE1ODVhM2I2ZWQ4MjhmMzMvdGFibGVyYW5nZTplZTE4MTNhMDQzMjc0ZTc0YTU4NWEzYjZlZDgyOGYzM18wLTEtMS0xLTExODIw_2946a3db-91b6-4652-91e1-cf2e85d72013">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGFibGU6ZWZlYjQyNDFhMWQzNDNiYWIyN2VhOTAyNjQzN2QwODMvdGFibGVyYW5nZTplZmViNDI0MWExZDM0M2JhYjI3ZWE5MDI2NDM3ZDA4M18wLTEtMS0xLTExODIw_38e66d14-c235-4407-9286-d4f24177eadb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="ife5243831866497cb6d5b5db8de6e910_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiNTZkMTZlMmVjNTRhZGVhYjk2MzhlYmI3MTllMDlkL3NlYzpjYjU2ZDE2ZTJlYzU0YWRlYWI5NjM4ZWJiNzE5ZTA5ZF8xL2ZyYWc6Yzk0MWYwMjA1MGYwNDM5N2JjZmE1YjI1MTYzNWQ3Y2YvdGV4dHJlZ2lvbjpjOTQxZjAyMDUwZjA0Mzk3YmNmYTViMjUxNjM1ZDdjZl8yMjU0_57d09b75-d112-410d-858b-e3be3af08f71">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Y(-O5!E%%?4W 0  )P(   \
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ Y(-O5&60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( .2#;U0%,QM*[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .2#;U297)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ Y(-O5&A #5_; P  !@\  !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .2#;U2?H!OPL0(
M .(,   -              "  1X,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  '83      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="csbr-20220315.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="csbr-20220315.htm">csbr-20220315.htm</File>
    <File>csbr-20220315.xsd</File>
    <File>csbr-20220315_lab.xml</File>
    <File>csbr-20220315_pre.xml</File>
    <File>csbr8-k1312022ex991xq322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "csbr-20220315.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "csbr-20220315.htm"
     ]
    },
    "labelLink": {
     "local": [
      "csbr-20220315_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "csbr-20220315_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "csbr-20220315.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 21,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "csbr",
   "nsuri": "http://championsoncology.com/20220315",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220315.htm",
      "contextRef": "ife5243831866497cb6d5b5db8de6e910_D20220315-20220315",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://championsoncology.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "csbr-20220315.htm",
      "contextRef": "ife5243831866497cb6d5b5db8de6e910_D20220315-20220315",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r3": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r4": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-22-006255-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-006255-xbrl.zip
M4$L#!!0    ( .2#;U3KQG3;*!0  'Z?   1    8W-B<BTR,#(R,#,Q-2YH
M=&WM7>U7XDK2_[Y_13_L>7:=<VSHO)$$9]SC%?0RUX0141>^>#KIC@1"PDV"
MO/SU6YV (XJ..N,,.,PY@X3T2U5W=?VJJBN=C_^9# )TP^/$C\)/!:E("N@_
M^Q__#^/__M$\0=7('0UXF*+#F-.4,S3VTRZZ9#SI(R^.!N@RBOO^#<4XJW,8
M#:>Q?]U-D4QD^=[-N"(3KBBF2[%,706K7-,QY;*#'=/0=$ZHQ\IT][K"H91+
MB(=-C92Q*G$74[?,,6&FKNI4TS1*=EG%=;0RD\I<YJZF4L:I8Y85@SN.+IF<
MF$QTVTV!.^ P3#X5NFDZK)1*X_&X.%:*47Q=DDS3+$U$F4)>J#()_+#_>%%Q
M=U'4GZ1+!2=.'&1%_1"*<3%\I32F8>)%\8"F,+PE&!2"B8PE>=$(X_YM(UD#
M"7>+U]%-"6Z(XM+7WE9W)A-)N=/C+1^)OXH+F1"I]%_KY,SM\@'%?IBD-'3Y
M'98P$+!4<T'04UQ)&B8&5FZ)%=3YC]%+!+W+_3X8].7BXK9#D[QX):#A]:<"
M#_'Y60$FF%.V_W' 4XI$?<S_'ODWGPJ'49B"V.+6= C5W/SJ4R'ED[24S7=I
M_Q__^,?'U$\#ON\F3HR%P!)%TCZ6\A\_EO*FG8A-]S\R_P8EZ33@GPK,3X8!
MG5;"*.1 @#^IB((\SK_ZC/$P^PKW;5@[L>_F_4_2)O<^%7R/:[*J&(IDE,NJ
MJ;M.F6F.QAR#\3(W)7)579!R2U,!A70@NN9^I18"?=-#8">F03UD?/(7GQ:0
MSZ!IIEQ,G6IT<R(W;]J*-6*]VDWGV.PU!K9OMSI]J]4)K,%%SVXUNYWCBVZ[
MUY>M63=H#^J*U0H"JQKT3Q0[:,^&O7;O7.Y4:W*G]1FNSTG[LAFT+^N:W;/4
MSN5GWY[5M$[K0.L<&>1$[DS;EVZY4;4F5I5U.ZUNOSTX)_;Q^<RZK,\ZO8.I
M?0Q]M]JDW6H.[./:#3L^\IWC\W*GU9]!O:D]JVN=:EVUC^N2H*O=8X-VRPXZ
M+>9;4-^JMN=U+J O+>RTAD&C9:G6#&CO!7VK=TW:O0N_T>KXMMSI6O)%8,MU
MJ%<?VX$Q/FG54NN,3.#OI &_73FRJDHJK$;5->##(!IV7,W 7)<X*!K-TZE;
MV"?P3]<E0RM_+"U-ZEO.\0&H7";4[E% KPLH7VK0["2M>/Z$,^S10"R'[:0_
M/>F3!Y-.>-EP!):4B4 @JBJ8.@H1,*0YBFLPF4F%_:.#D[/:@_DN+:_OF'L\
MYJ#%DA5J2:BL2I)I69 (E %')05E]*F0^(-A('19]ELW%@*SI(&*DX1!$Z7E
M-O+^OW8ZIR&)1G%VE>G<REP*<\EXC10N&N*9FEE<^4Q<>SZ/44807PD1A_6_
MEA?,_<K[BY^66Q_"^$9L<070$*=5,#;V!5&8*%@HY?OW;LEDCQ1=W%E<+SHI
M+0W48E1OA[%T1Y^70.OGJC\;SF_9&U=2X6Z=.5P,_!!WN;")*JI<U+5ANC?V
M6=JM2(3\?R$KNO\Q&5(0*B<N00/Y][R=!ZT)>,9 =TS=M)*,!@,:3_?@XQIZ
M2:-A130O^,(T\*_#B@L#S6/H):5.P!>-.%$,_&$W"@(Z3'AE\65O 6TYUN.L
MTJ)U)TK3:)!U -9BZKLTF'>2]9??GK-FZD59E@5W*0QCRA8=SQDO9HR74K;B
MGE$TR>.W25%ZO.JVV1_6;"F;MWA18"Z_RC M9/5 8(24?BHHA7LR-9<2*(E8
M-!(R]T^2_=L;4L;\\+I"D)0ULZ!AV]8+VLKFI92MRQ7*8=7"?TRS/*/:XCY0
M'\65!5T>*$ZP/P9^,*W\N^4/ /YL/D;-:$##?^\FX!F CHI]+R^8^#,.F@Z4
M1G8YS@5)AW8R#3,7+$D68GENUUNU*CIK';1J9^BL=GC>K+?J\/7 KJ+:?P__
M/  3 ATV+*M^=E9OV&O$D+J2H<N#LS_K]G&K8>^B:O&P"$ZQIIIK3_:__BF5
MR=X#,M=4EE[$P[J)_%&C::$W="06X9O<#?Z5[L)DX2ZT9WUB7;;'8-Y+UG%[
M;%<MS98_]SJ#&K@ =0G<A9E]>:JT96'Z7ZCLS\]!1PYNG-ZPUVB=3CJ96W ^
MAK_$FO65]L &E^$"W(7S"?0K=:JLUPF,J;B^,CCCNNK"X*AN&7P\EV'34TRL
M@(-'7<53=0:FMH'_>FCL?UMR>J,$S-KI+Q*=#9%P4.+-FMU"S=J71K.%OIPW
MS\X/X+K5$!J^!6H<20IJ-)&D[; /J'&T]ARU_JS=!:=;8#HX; 'Y2#(5=9VD
M9T/TXVHRA0>'(@_%?!C%*=I97',*/AQ/4L1O1' ZO\W9A\K/4*9?,D^REON7
MR]$9!K_@ ?39%=4PHU,\!5HQ#W\O[3MK5$]5J]<?V[T^T%.?7GE$E57']3!3
M'!6KW'"Q([LF+DM>62*RX;J$%_8M&KM=4 6[V?[!5BF_F$SC662^>7BZR:_]
M1&P3I#;<^;UD'RR/4_E*T0TP/@P3NV6-@>51-K#!M#(V'-UE(.VN:H*\ W18
M7P #SU##/FR<-([;NZAN'Q9?(_E;>_O;9.[4)M1-,W'-864AIH@F*!ER5X0I
M&?)#Y*<)<KL44"7^L/9L?6/TE^.#/S\::!8-37E--% A14W67A4(>^J>7-2,
MU]5\BEC9+)J*N2'$PLB6=?4EL<#' EF+.)4\G(A(U</H\WT!R67CYP,T^2G(
M5P_=* 9K--L:/TO!'CR,1F$:3P\CMFPLBE"^V-!(^3".;D0[&VHEYEMZ[98%
M-!Q G=JT4ZU/[.-SS9Y=RXU67;9:K&L/SB>=X[K2J9[>W]+K6K/VS*H"NK8^
M]Z$^Z;3Z2J/:UJQ>>V++@O:C?KO'^O:1V,<]6-[2X[(NETWF8I@WL"S+8%F:
M94?#1MGENNX08BH*>!(\H&,:\T>1]?%0[69)^#TL>"]LO?G"/?(##JT[ .+;
M1?CM15A?7H2:23R'<'#O9$*QZA$%FRIUL.EI7'-<KG'AWA$B84G2B/IC5^'<
MYULK>=TNP]<MPQ:=U.?Y FZ&H=LU^>PU>;J\)JGLZ&4J44PX%<"H"1>4RAC6
MHJ0JCJM+C!3V-1E+*I%T37MR46ZH%?C 7\JD>"<SS% 4HT;:Y3'Z/(K]A/FN
MD+<-7K*KF=UX3?3('!Y&@X&?B+1E)+ ;Y8KBPR9#R>\U@?7F&:H-AD$TY?'[
MU361AY9\PN\4T#7D\)W*YX]@:ZM.?AI;RU8CLJ/BAX=*Y3FI4]N-V77803I@
M+.9),O]S @1(&^D#?%<"BW0EF]R1==,$;UIB6)4IQ]1QRMC5/<4S=%-EFE[8
ME]!YZ&?/<*53]"6@,WK?EM]]RXWQQV9,_OUF3+XBW*2JHRD8/BE6);.,34=Q
ML"9+W.,N!1=,*>R?C7QP0!2B_[J).H2OC;@5C3<SZOQ=^[/JE<D)54Q/QV7=
M("(S3,&.P1F6*"7< [?9-<J%_3^IV^=A I^_;IXR7[41?XFC&S][9NX][B%\
MUVQJ5YKC&)ILE#&L- >KBNYA1R\S##^;,O=<*BNLL"^P[S-H23Z]/YL_;3*_
M1#!;0<<?YMM!O]E,G<^N'$XU4H:9HI(D Z Y+C8<!M"F>:[B*1+GC@@4ZV4B
M;5P2Q,Y\DD5JP9<8%JL_I &J3;@[2@&>4<,#\Y0GS\HGV!0K]-?2^37/Z%__
M-&1)WTM0R@,^[$8A1V$6$-I%,!'!2'@RB,:<PMIFO((6O/T*XWGG#;6-0/4#
M8//WTR^D4;6N3"+I3IF"]>7*!E9-DCW?R3!S54H89T[VC*/\4+E\>$L(.(G
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M3@5&N2/YF89P/<V'79%RRHOH );#\#9I_7YORY2)6%N:4O!I&>KRF(/+2$6
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MJY7(@)K@I?EQ?0 XRU$:B!94DI2!(\9)(-3K+,V,$,+0?M&RJ#X<="_6-+#
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MI*GKO9N29 **_R6:6&T#"9"N=G_.5[MP=;5+!3_,3!^F!9JM$;^JZ\_(C%&
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MMGM:_Z!F'[[64_5S=-8ZD 8E=!8N6E9].JOMV&QZ'OFFP\>SP\7UZ7<\7KS
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M^YI)TBH_XE [D!7QC&#J,?LS<:<34,J;>.)\3[$L:9Y7GDFJ);<C/*[+S@M
MCXA9.#F!J5Y#R.U]EJ+4&!K$H8:I"[\$@7/O>E[#= /#D >J2A9)QSUWW!=K
M >=UI,I3GJHR<,-0NF9'.I#/I:O)>=2,>:3WE:ZER7E4^4",K#%W&<Z,>6;B
ME,[XKBST>%+;#A/F$,^E ]=S8Y?MK=A46>:>J$YI)<7JAA0KI=\[L 9$C90
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M<BTR,#(R,#,Q-2YH=&U02P$"% ,4    " #D@V]4A!_AW74"  "*!P  $0
M            @ %7%   8W-B<BTR,#(R,#,Q-2YX<V102P$"% ,4    " #D
M@V]4\TXB4X )  ! 5@  %0              @ '[%@  8W-B<BTR,#(R,#,Q
M-5]L86(N>&UL4$L! A0#%     @ Y(-O5,J'!0-$!@  #"T  !4
M     ( !KB   &-S8G(M,C R,C S,35?<')E+GAM;%!+ 0(4 Q0    ( .2#
M;U18>K*AR"4  #B. @ <              "  24G  !C<V)R."UK,3,Q,C R
E,F5X.3DQ>'$S,C(N:'1M4$L%!@     %  4 3@$  "=-      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
